Joseph Kerger
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Otorhinolaryngology top 2%
Papers in
- Oncology 46
- Cancer Treatment and Pharmacology 19
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Surgical Treatments 5
-
- Ovarian cancer diagnosis and treatment 9
- Co-authors
- Lionel DuckMartine PiccartJ-P. MachielsRobert ParidaensAhmad AwadaYves HumbletValentina BoniAna Oaknin
In The Last Decade
Joseph Kerger
68 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.5k
- Otorhinolaryngology 171
- Obstetrics and Gynecology 227
- Reproductive Medicine 242
- Pulmonary and Respiratory Medicine 606
Countries citing papers authored by Joseph Kerger
This map shows the geographic impact of Joseph Kerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Kerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Kerger more than expected).
Fields of papers citing papers by Joseph Kerger
This network shows the impact of papers produced by Joseph Kerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Kerger. The network helps show where Joseph Kerger may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph Kerger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2020 | 32 | |
| 4 | 2020 | 15 | |
| 5 | 2020 | 5 | |
| 6 | 2017 | 36 | |
| 7 | 2017 | 36 | |
| 8 | 2016 | 11 | |
| 9 | 2015 | 100 | |
| 10 | 2013 | 24 | |
| 11 | 2010 | 133 | |
| 12 | 2008 | 48 | |
| 13 | 2007 | 118 | |
| 14 | 2005 | 106 | |
| 15 | Chinese herbs nephropathy and urinary tract carcinoma | 1998 | 2 |
| 16 | Phase I clinical study of Docetaxel (TXT) in combination with continuous infusion (CI) Fluorouracil (5-FU) in patients (pts) with advanced solid tumors | 1996 | 1 |
| 17 | 1994 | 125 | |
| 18 | Etoposide oral administré de manière prolongé: un traitement partiellement non cross-résistant avec les dérivés Taxanes dans le cancer de l’ovaire | 1993 | 1 |
| 19 | A phase I clinical trial of recombinant human interleukine-6 (rhIL-6) in solid tumors | 1992 | 1 |
| 20 | A phase I study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis | 1991 | 12 |
About Joseph Kerger
Joseph Kerger is a scholar working on Oncology, Reproductive Medicine, Otorhinolaryngology, Obstetrics and Gynecology and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (19 papers), Lung Cancer Treatments and Mutations (10 papers), Melanoma and MAPK Pathways (9 papers), Ovarian cancer diagnosis and treatment (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Colorectal Cancer Surgical Treatments (5 papers). The work is most often cited by research in Oncology (1.5k citations), Otorhinolaryngology (171 citations), Obstetrics and Gynecology (227 citations), Reproductive Medicine (242 citations) and Pulmonary and Respiratory Medicine (606 citations). Joseph Kerger has collaborated with scholars based in Belgium, France and Spain. Frequent co-authors include Lionel Duck, Martine Piccart, J-P. Machiels, Robert Paridaens, Ahmad Awada, Yves Humblet, Valentina Boni, Ana Oaknin, Suzanne L. Topalian and José M. López-Picazo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancers and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.